Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in ... trends now

Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in ... trends now
Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in ... trends now

Miracle diabetes jab Ozempic 'halves severe heart failure symptoms' in ... trends now

Semaglutide is the active ingredient in Ozempic 

View
comments

Miracle diabetes jab Ozempic has been hailed as 'a paradigm shift' in the battle against deadly heart failure.

A trial has found that patients given semaglutide – the active ingredient in Ozempic – were half as likely to suffer severe symptoms of the condition, including breathlessness and fatigue.

Heart failure is an incurable long-term condition that causes the heart to stop pumping effectively. 

It affects about one million Britons which often leaves them housebound and needing regular hospital treatment – and one in five patients do not survive longer than a year from diagnosis.

Semaglutide was originally developed as a diabetes treatment, but in recent years has become one of the world's most in-demand weight-loss drugs after it was shown to dramatically suppress appetite, with a host of celebrities, including Elon Musk and Boris Johnson, admitting to taking it in a bid to slim down.

Elon Musk (pictured) admitted to taking the medication in a bid to slim down

Elon Musk (pictured) admitted to taking the medication in a bid to slim down

A trial has found that patients given semaglutide – the active ingredient in Ozempic – were half as likely to suffer severe symptoms of the condition, including breathlessness and fatigue

A trial has found that patients given semaglutide – the active ingredient in Ozempic – were half as likely to suffer severe symptoms of the condition, including breathlessness and fatigue

The breakthrough in its use as a treatment for heart failure was announced at the American College of Cardiology conference in Atlanta yesterday.

read more from dailymail.....

NEXT UK's prostate cancer revolution: 'Biggest trial in a generation' could lead to ... trends now